Pharmacokinetics, Safety, and Tolerability of GS‐1427, an Oral Prodrug of a Potent and Selective α4β7 Integrin Inhibitor, in Healthy Participants

Documenti analoghi

• Pharmacokinetics, Mass Balance, Safety, and Tolerability of Obeldesivir in Healthy Participants
  di: Olena Anoshchenko, et al.
  Pubblicazione: (2024)
• Safety, Tolerability, and Pharmacokinetics of Single‐ and Multiple‐Ascending Doses of Sunobinop in Healthy Participants
  di: Alessandra Cipriano, et al.
  Pubblicazione: (2024)
• Comparability of Elezanumab Safety, Tolerability, and Pharmacokinetics in Healthy Japanese, Chinese, and White Participants
  di: Hari V. Kalluri, et al.
  Pubblicazione: (2024)
• Safety, Tolerability, and Pharmacokinetics of Galcanezumab, an Anti‐CGRP Antibody, in Healthy Chinese Participants
  di: Jingjing Wang, et al.
  Pubblicazione: (2025)
• Effect of Food on the Pharmacokinetics, Safety, and Tolerability of Budesonide Oral Suspension in Healthy Adult Participants: A Randomized Phase 1 Study
  di: Alexander J. Prokopienko, et al.
  Pubblicazione: (2024)